Meacham’s man­i­festo to Gilead: It’s time to do some­thing dra­mat­ic — buy, bag or burn

Af­ter watch­ing Gilead’s pipeline fal­ter in the sec­ond half of last year fol­lowed by a stun­ning fore­cast of rapid­ly shrink­ing rev­enue for its hep C fran­chise, Bar­clays se­nior an­a­lyst Ge­off Meacham has had it. In an un­usu­al pub­lic broad­side aimed at Gilead $GILD CEO John Mil­li­gan and his ex­ec­u­tive team, Meacham threw down the gaunt­let in an open let­ter to man­age­ment, call­ing out plays from the bleach­ers de­signed to spur the big biotech to buy some­thing and even pos­si­bly re­struc­ture if the num­bers de­te­ri­o­rate much fur­ther.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.